Oxford Endovascular is a spin out  from Oxford University developing technology to prevent brain haemorrhage.

OxiFlow™️ is a novel, next generation flow-diverter, laser-cut from nitinol that diverts blood flow away from intracranial aneurysms at risk of rupture. Competitors have adverse events related to poor placement of devices due to their inherent design weaknesses. OxiFlow™️  is a unique design that places more accurately and safely than existing products, reducing risk of complications and conforms to blood vessel shapes making more patients treatable. Patented in Europe, US, China & Japan.

Created by world experts in the field, OxiFlow™ has gone through proof of concept pre-clinical studies that will be followed by a 1st in human study en-route to gaining FDA & CE mark.

Oxford Endovascular Ltd.

Penumbra is a company that develops and manufactures medical devices for neurovascular and peripheral vascular applications.

Penumbra

Rapid Medical is a medical device company focused on the development of neurovascular devices for the treatment of stroke and aneurysms.

Rapid Medical

Stryker is a leading global medical technology company that offers a wide range of products and services in the neurovascular field.

Stryker

Johnson & Johnson is a multinational corporation with a significant presence in the healthcare industry, including neurovascular devices.

Johnson & Johnson

Medtronic plc is a global leader in medical technology, services, and solutions, including neurovascular interventions.

Medtronic plc

Terumo Corporation is a Japanese multinational medical devices and pharmaceutical company with a focus on neurovascular interventions.

Terumo Corporation

Oxford Endovascular Ltd is a medical device company that specializes in the development of innovative solutions to treat brain hemorrhages. The company's flagship product, the Origami device, is designed to prevent brain hemorrhage and is based on technology developed at the University of Oxford's Department of Physics.

Oxford Endovascular Ltd

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

financial_statements

network_onboarding

company_summary

signals

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

news_processing_advanced

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general
public peers	general	Jun 21, 2024 10:05 PM	5121a4c0
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jun 22, 2024 12:44 AM	91dc2019
company summary	general
signals	general
news advanced	general
news impact assignment advanced	general
news processing advanced	general
peers	general
news basic	general	Jun 21, 2024 10:05 PM	68703ec5
events	markdown
bundesanzeiger	filings
financial statements	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
purchaser profile	merger_acquisitions
customer profile	customers

COM:OXFORDENDOVASCULAR

Oxford Endovascular Ltd